The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.

The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.

COVID-19 has little impact on patients with dermatological immune-mediated inflammatory diseases, with effective ...

With the Trump administration announcing plans to impose 25% tariffs on pharmaceuticals, it reignites a critical discussion ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

Seasonal influenza has reached its highest levels in over 15 years and has now surpassed COVID-19 deaths for the past two ...

We recently compiled a list of the 12 Best Get Rich Fast Stocks To Buy Now. In this article, we are going to take a look at ...

The world-wide pandemic involving SARS-CoV2 in which high infectivity and pathogenesis necessitated the critical need for rapid and accurate preclinical ...

A new laser-based device can scan almost any sample of gas and detect its molecular ingredients down to concentrations in the parts per trillion.

As COVID-19 surged across the US starting in 2020, so too did the use of repurposed medications such as hydroxychloroquine and ivermectin to treat COVID-19 infections. Use of these medications ...

COVID-19 vaccines have been instrumental in reducing the impact of the pandemic, preventing severe illness and death, and ...

Pembrolizumab is a checkpoint inhibitor that binds to the protein PD-1 on T cells to help them recognize and attack invaders.